This is a swab used for "wipe tests" conducted in food and medical settings.
- Efficient detection of surface-adhering bacteria and measurement of bacterial counts is possible. - The larger cap makes it easy to hold even while wearing gloves. - The soft plastic makes it easy to squeeze cotton balls. Raspa Check is a swab used for "wiping tests" conducted in food and medical settings. Wiping tests can capture surface adherences in environments without being limited by curved or uneven surfaces. Using the swab, surfaces of cutting boards, hands, food ingredients, medical instruments, and medical equipment are wiped, and through the dilution method and streaking method, detection of surface-adhering bacteria and measurement of bacterial counts are performed.
Inquire About This Product
basic information
Swabbing Method 1) Wipe a fixed area of the surface (e.g., 10cm x 10cm) vigorously and thoroughly in all directions at an angle of approximately 20-30°, allowing the rinse solution to be sufficiently extracted to create a sample solution. 2) Dispense 1mL of the sample solution into a Petri dish, then add approximately 15-20mL of pre-sterilized and temperature-controlled (48-50°C) culture medium to the Petri dish, mix thoroughly by rotating it in all directions, and allow it to solidify in a horizontal position for cultivation under appropriate conditions. 3) Convert the number of bacteria in the extracted liquid to a viable count per unit area of the swab. (Example) Viable count per cm² = Average colony count/mL × Volume of extracted liquid ÷ Swabbed area
Price information
Please feel free to contact us.
Price range
P1
Delivery Time
※[Order Management Department] 0120-8555-90 (Voice Guidance: Option 1)
Applications/Examples of results
Please contact us.
Line up（1）
| Model number | overview |
|---|---|
| 251811 | BD Raspar Check™ Swab for wipe test |
catalog（1）
Download All Catalogs
Company information
BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.
